,outcome,arm 1,arm 2
0,intervention,"CHF, TLC D-99 patients",doxorubicin patients
0,Protocol-defined cardiotoxicity,"13 %, including 2 cases",29 %
0,"Protocol-defined cardiotoxicity, total study group",including 9 cases,including 9 cases
